Login to Your Account

U.S. FDA bolsters investigator presence in China by 10

By Cornelia Zou
Staff Writer

Wednesday, December 11, 2013

HONG KONG – The U.S. FDA plans to add 10 more investigators to its China office to enhance its monitoring of Chinese exports of pharmaceuticals to the U.S.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription